PSNC Briefing 062/19: Serious Shortage Protocols (SSPs): SSP04 – Haloperidol 500 microgram capsules (Serenace®)

PSNC Briefing 062/19: Serious Shortage Protocols (SSPs): SSP04 – Haloperidol 500 microgram capsules (Serenace®)

In response to significant ongoing disruption to the supply of Haloperidol 500 microgram capsules (Serenace®), a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC), which can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on the SSP and is intended as a short guide for contractors to read in conjunction with PSNC Briefing 023/19: Serious Shortage Protocols (SSPs) – A guide for community pharmacy teams.

PSNC Briefing 062/19: Serious Shortage Protocols (SSPs): SSP04 – Haloperidol 500 microgram capsules (Serenace®)

If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.

To browse other PSNC briefings on dispensing and supply click here.



Latest Dispensing and Supply news

View more Dispensing and Supply news >

Wuhan Novel Coronavirus

The Medicines & Healthcare products Regulatory Agency (MHRA) has via its Central Alerting System (CAS) published an alert regarding the...